A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease
Bruce M. Prenner MD, Stan Bukofzer MBBCh, MMed (Int), Sarah Behm BS, Kathleen Feaheny MS, Bruce E. McNutt MDVolume:
19
Language:
english
Pages:
12
DOI:
10.1007/s12350-012-9547-4
Date:
August, 2012
File:
PDF, 343 KB
english, 2012